Form 4 for ATEX Anterix Inc.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-25 · accession 0001209191-22-058892 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-28 | 2022-11-25 | ATEX | Guttman-McCabe Christopher | Chief Reg, Comm Off | S - Sale | $36.21 | -8,332 | 54.4K | -13% | -$301.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-25 | S | D | 8,332 | $36.21 | 54,352 | D | — | — | (F1) This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $35.93 to $36.64. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |